• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敲低 GTSE1 通过 DNA 损伤修复通路增强非小细胞肺癌的放射敏感性。

Knockdown GTSE1 enhances radiosensitivity in non-small-cell lung cancer through DNA damage repair pathway.

机构信息

Department of Radiation Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

出版信息

J Cell Mol Med. 2020 May;24(9):5162-5167. doi: 10.1111/jcmm.15165. Epub 2020 Mar 22.

DOI:10.1111/jcmm.15165
PMID:32202046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7205821/
Abstract

Radiotherapy is an important strategy for NSCLC. However, although a variety of comprehensive radiotherapy-based treatments have dominated the treatment of NSCLC, it cannot be avoided to overcome the growing radioresistance during radiotherapy. The purpose of this study was to elucidate the radiosensitizing effects of NSCLC via knockdown GTSE1 expression and its mechanism. Experiments were performed by using multiple NSCLC cells such as A549, H460 and H1299. Firstly, we found GTSE1 conferred to radioresistance via clonogenic assay and apoptosis assay. Then, we detected the level of DNA damage through comet assay and γH2AX foci, which we could clearly observe knockdown GTSE1 enhance DNA damage after IR. Furthermore, through using laser assay and detecting DNA damage repair early protein expression, we found radiation could induce GTSE1 recruited to DSB site and initiate DNA damage response. Our finding demonstrated that knockdown GTSE1 enhances radiosensitivity in NSCLC through DNA damage repair pathway. This novel observation may have therapeutic implications to improve therapeutic efficacy of radiation.

摘要

放射治疗是 NSCLC 的重要策略。然而,尽管各种基于综合放射治疗的治疗方法已经主导了 NSCLC 的治疗,但在放射治疗过程中克服不断增长的放射抗性是不可避免的。本研究旨在通过敲低 GTSE1 表达来阐明 NSCLC 的放射增敏作用及其机制。实验通过使用多种 NSCLC 细胞(如 A549、H460 和 H1299)进行。首先,我们发现 GTSE1 通过集落形成实验和细胞凋亡实验赋予放射抗性。然后,我们通过彗星实验和 γH2AX 焦点检测来检测 DNA 损伤水平,我们可以清楚地观察到敲低 GTSE1 增强了 IR 后的 DNA 损伤。此外,通过使用激光实验和检测 DNA 损伤修复早期蛋白表达,我们发现辐射可以诱导 GTSE1 募集到 DSB 位点并启动 DNA 损伤反应。我们的发现表明,通过 DNA 损伤修复途径,敲低 GTSE1 可增强 NSCLC 的放射敏感性。这一新的观察结果可能具有治疗意义,可提高放射治疗的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f43/7205821/cefd7f3b0223/JCMM-24-5162-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f43/7205821/b545182b1666/JCMM-24-5162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f43/7205821/c1b1da28d6f8/JCMM-24-5162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f43/7205821/2f60df6b9286/JCMM-24-5162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f43/7205821/cefd7f3b0223/JCMM-24-5162-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f43/7205821/b545182b1666/JCMM-24-5162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f43/7205821/c1b1da28d6f8/JCMM-24-5162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f43/7205821/2f60df6b9286/JCMM-24-5162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f43/7205821/cefd7f3b0223/JCMM-24-5162-g004.jpg

相似文献

1
Knockdown GTSE1 enhances radiosensitivity in non-small-cell lung cancer through DNA damage repair pathway.敲低 GTSE1 通过 DNA 损伤修复通路增强非小细胞肺癌的放射敏感性。
J Cell Mol Med. 2020 May;24(9):5162-5167. doi: 10.1111/jcmm.15165. Epub 2020 Mar 22.
2
Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity.敲低核仁素表达通过影响DNA依赖蛋白激酶催化亚基(DNA-PKcs)活性增强非小细胞肺癌的放射敏感性。
Asian Pac J Cancer Prev. 2015;16(8):3301-6. doi: 10.7314/apjcp.2015.16.8.3301.
3
DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses.DDB2通过增强DNA损伤反应来增加非小细胞肺癌细胞的放射抗性。
Tumour Biol. 2016 Oct;37(10):14183-14191. doi: 10.1007/s13277-016-5203-y. Epub 2016 Aug 23.
4
Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair.靶向AKT1通过抑制DNA-PKcs依赖的DNA双链断裂修复增强人肿瘤细胞的辐射毒性。
Mol Cancer Ther. 2008 Jul;7(7):1772-81. doi: 10.1158/1535-7163.MCT-07-2200.
5
The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure.多分次放疗后 p53-53BP1 相关的 A549 和 H1299 人肺癌细胞存活展示了对额外急性 X 射线照射的不同反应。
Int J Mol Sci. 2020 May 8;21(9):3342. doi: 10.3390/ijms21093342.
6
The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.多分割照射存活 NSCLC 细胞的 CD44high 亚群根据其 p53 状态表现出部分 EMT 程序激活和 DNA 损伤反应。
Int J Mol Sci. 2021 Feb 27;22(5):2369. doi: 10.3390/ijms22052369.
7
Knockdown of Lncrna PVT1 Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Sponging Mir-195.下调长链非编码RNA PVT1通过吸附miR-195增强非小细胞肺癌的放射敏感性。
Cell Physiol Biochem. 2017;42(6):2453-2466. doi: 10.1159/000480209. Epub 2017 Aug 22.
8
Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma.Survivin 抑制与 DNA 双链断裂修复:克服脑胶质瘤放射抵抗的分子机制。
Radiother Oncol. 2011 Oct;101(1):51-8. doi: 10.1016/j.radonc.2011.06.037. Epub 2011 Aug 16.
9
Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non-Small Cell Lung Cancer and .阿贝西利,一种选择性 CDK4/6 抑制剂,增强非小细胞肺癌的放射敏感性。
Clin Cancer Res. 2018 Aug 15;24(16):3994-4005. doi: 10.1158/1078-0432.CCR-17-3575. Epub 2018 May 1.
10
Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.转化生长因子-β抑制剂对DNA损伤反应的减弱增强了非小细胞肺癌细胞在体外和体内的辐射敏感性。
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):91-9. doi: 10.1016/j.ijrobp.2014.09.026.

引用本文的文献

1
Targeting DNA Damage Response-Mediated Resistance in Non-Small Cell Lung Cancer: From Mechanistic Insights to Drug Development.靶向非小细胞肺癌中DNA损伤反应介导的耐药性:从机制洞察到药物开发
Curr Oncol. 2025 Jun 23;32(7):367. doi: 10.3390/curroncol32070367.
2
Immunological biomarkers and gene signatures predictive of radiotherapy resistance in non-small cell lung cancer.预测非小细胞肺癌放疗抗性的免疫生物标志物和基因特征
Front Immunol. 2025 May 29;16:1574113. doi: 10.3389/fimmu.2025.1574113. eCollection 2025.
3
A scATAC-seq atlas of stasis zone in rat skin burn injury wound process.

本文引用的文献

1
Current status and development of anti-PD-1/PD-L1 immunotherapy for lung cancer.肺癌抗 PD-1/PD-L1 免疫治疗的现状与展望。
Int Immunopharmacol. 2020 Feb;79:106088. doi: 10.1016/j.intimp.2019.106088. Epub 2019 Dec 31.
2
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.非小细胞肺癌靶向治疗的新兴治疗领域。
Signal Transduct Target Ther. 2019 Dec 17;4:61. doi: 10.1038/s41392-019-0099-9. eCollection 2019.
3
Cell Death Response to DNA Damage.细胞对 DNA 损伤的反应。
大鼠皮肤烧伤创面愈合停滞期的单细胞染色质转座酶可及性测序图谱
Front Cell Dev Biol. 2025 Jan 7;12:1519926. doi: 10.3389/fcell.2024.1519926. eCollection 2024.
4
Comprehensive analysis of the diagnostic and therapeutic value, immune infiltration, and drug treatment mechanisms of GTSE1 in lung adenocarcinoma.GTSE1在肺腺癌中的诊断和治疗价值、免疫浸润及药物治疗机制的综合分析
Front Med (Lausanne). 2024 Nov 19;11:1433601. doi: 10.3389/fmed.2024.1433601. eCollection 2024.
5
[Relationship between GTSE1 and Cell Cycle and Potential Regulatory Mechanisms 
in Lung Cancer Cells].[GTSE1与肺癌细胞中细胞周期的关系及潜在调控机制]
Zhongguo Fei Ai Za Zhi. 2024 Jun 20;27(6):451-458. doi: 10.3779/j.issn.1009-3419.2024.106.13.
6
GTSE1 promotes nasopharyngeal carcinoma proliferation and angiogenesis by upregulating STMN1.GTSE1通过上调STMN1促进鼻咽癌增殖和血管生成。
Cell Div. 2024 May 2;19(1):16. doi: 10.1186/s13008-024-00119-9.
7
LKB1 Mutations Enhance Radiosensitivity in Non-Small Cell Lung Cancer Cells by Inducing G2/M Cell Cycle Phase Arrest.LKB1突变通过诱导G2/M期细胞周期阻滞增强非小细胞肺癌细胞的放射敏感性。
Curr Mol Med. 2025;25(3):353-360. doi: 10.2174/0115665240280822231221060656.
8
[Icaritin increases radiosensitivity of nasopharyngeal carcinoma cells by regulating iron death].淫羊藿素通过调控铁死亡增加鼻咽癌细胞的放射敏感性
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Oct 20;43(10):1665-1673. doi: 10.12122/j.issn.1673-4254.2023.10.03.
9
Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer.综述:非小细胞肺癌放射抵抗的机制和治疗视角。
Front Immunol. 2023 Feb 14;14:1133899. doi: 10.3389/fimmu.2023.1133899. eCollection 2023.
10
Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways.猫乳腺肿瘤及其衍生细胞系的转录谱分析揭示了与代谢和细胞周期途径相关的生物标志物和药物靶点。
Sci Rep. 2022 Oct 11;12(1):17025. doi: 10.1038/s41598-022-20874-5.
Yale J Biol Med. 2019 Dec 20;92(4):771-779. eCollection 2019 Dec.
4
Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer.立体定向体部放射治疗非小细胞肺癌寡转移灶
Front Oncol. 2019 Nov 12;9:1219. doi: 10.3389/fonc.2019.01219. eCollection 2019.
5
Hyperthermia with photon radiotherapy is thermoradiobiologically analogous to neutrons for tumors without enhanced normal tissue toxicity.光子放疗的高热与肿瘤的中子热放射生物学类似,而不会增加正常组织的毒性。
Int J Hyperthermia. 2019;36(1):1073-1078. doi: 10.1080/02656736.2019.1679895.
6
Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia.DNA-PK 抑制剂对头颈部鳞状细胞癌细胞系的放射增敏作用优于 PARP-1 抑制作用,并可被 SLFN11 和缺氧增强。
Int J Radiat Biol. 2019 Dec;95(12):1597-1612. doi: 10.1080/09553002.2019.1664787. Epub 2019 Sep 17.
7
Reaction of Electrons with DNA: Radiation Damage to Radiosensitization.电子与 DNA 的反应:辐射损伤与增敏。
Int J Mol Sci. 2019 Aug 16;20(16):3998. doi: 10.3390/ijms20163998.
8
Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer.小细胞肺癌分子靶向治疗的未来选择
Cancers (Basel). 2019 May 17;11(5):690. doi: 10.3390/cancers11050690.
9
GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.GTSE1 依赖于 p53 突变参与乳腺癌的进展。
J Exp Clin Cancer Res. 2019 Apr 8;38(1):152. doi: 10.1186/s13046-019-1157-4.
10
Association of Expanded VA Hospice Care With Aggressive Care and Cost for Veterans With Advanced Lung Cancer.VA 扩大临终关怀与退伍军人晚期肺癌积极治疗和成本的关联。
JAMA Oncol. 2019 Jun 1;5(6):810-816. doi: 10.1001/jamaoncol.2019.0081.